CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
administration) to reduce maintenance therapy without loss of asthma control in adolescent and adults with severe asthma..Study det...
Phase 3
Windsor, Ontario, Canada and 70 other locations
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...
Phase 2
Toledo, Ohio, United States and 63 other locations
and potential efficacy of ENV-294 in adults with moderate to severe asthma who are receiving background treatment with inhaled corticosteroi...
Phase 2
Southfield, Michigan, United States of America and 10 other locations
The purpose of this study is to evaluate the efficacy and safety of verekitug (UPB-101) in participants with severe asthma. The study will e...
Phase 2
Farmington Hills, Michigan, United States of America and 157 other locations
study to evaluate the effect of timely treatment with mepolizumab (NUCALA) to achieve clinical remission in adult participants with severe asthma...
Phase 4
Ann Arbor, Michigan, United States and 64 other locations
The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...
Phase 3
Dearborn, Michigan, United States and 335 other locations
to therapy acting directly on the anti-IL-4R. This will be conducted by examining the effect of a 48 week therapy with dupilumab on the rate of asthma...
Phase 4
Detroit, Michigan, United States and 5 other locations
To assess the efficacy and safety of tezepelumab in pediatric participants with severe uncontrolled asthma on medium to high-dose inhaled co...
Phase 3
Ann Arbor, Michigan, United States and 141 other locations
Phase 2 study to evaluate the safety, tolerability, PK, immunogenicity, and pharmacodynamics of solriktug with adult participants with asthma...
Phase 2
Farmington Hills, Michigan, United States and 73 other locations
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Ypsilanti, Michigan, United States and 154 other locations
Clinical trials
Research sites
Resources
Legal